Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307527![]() ((R)-1-(3-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylam...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307526![]() ((S)-2-(N-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307525![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307523![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307520![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307521![]() (2-((4-((2-amino-4-(butylamino)-6-methylpyrimidin-5...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307522![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307524![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307528![]() ((S)-1-(3-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylam...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an aut... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307522![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Cell CultureThe hERG-expressing Chinese hamster ovary K1 (CHO) cells described by (Persson, Carlsson, Duker, & Jacobson, 2005) were grown to semi-con... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307524![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Cell CultureThe hERG-expressing Chinese hamster ovary K1 (CHO) cells described by (Persson, Carlsson, Duker, & Jacobson, 2005) were grown to semi-con... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307520![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Cell CultureThe hERG-expressing Chinese hamster ovary K1 (CHO) cells described by (Persson, Carlsson, Duker, & Jacobson, 2005) were grown to semi-con... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM307525![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Cell CultureThe hERG-expressing Chinese hamster ovary K1 (CHO) cells described by (Persson, Carlsson, Duker, & Jacobson, 2005) were grown to semi-con... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307520![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307521![]() (2-((4-((2-amino-4-(butylamino)-6-methylpyrimidin-5...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307522![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307523![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307524![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307525![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307526![]() ((S)-2-(N-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307527![]() ((R)-1-(3-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylam...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307528![]() ((S)-1-(3-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylam...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM433565![]() ((S)-3-((3-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307529![]() ((S)-3-((3-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307531![]() ((S)-2-((3-(4-((2-amino-4-(l-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307532![]() ((R)-1-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 8 (Homo sapiens (Human)) | BDBM307533![]() ((S)-1-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description TLR8/NF-kB/SEAPorter™ HEK 293 Cell Line (Imgenex Corporation) is a stably co-transfected cell line which expresses full-length human TLR8 and the sec... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307533![]() ((S)-1-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307532![]() ((R)-1-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307531![]() ((S)-2-((3-(4-((2-amino-4-(l-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307529![]() ((S)-3-((3-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM433565![]() ((S)-3-((3-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307528![]() ((S)-1-(3-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylam...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307527![]() ((R)-1-(3-(4-((2-amino-4-((S)-1-hydroxyhexan-3-ylam...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 126 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307526![]() ((S)-2-(N-(4-((2-amino-4-(1-hydroxyhexan-3-ylamino)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307525![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307524![]() ((S)-3-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 50.1 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307523![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307522![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 79.4 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307520![]() ((S)-2-((4-((2-amino-4-(1-hydroxyhexan-3-ylamino)-6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 158 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 7 (Homo sapiens (Human)) | BDBM307521![]() (2-((4-((2-amino-4-(butylamino)-6-methylpyrimidin-5...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 794 | n/a | n/a | n/a | n/a |
Sumitomo Dainippon Pharma Co., Ltd. US Patent | Assay Description Recombinant human TLR7 was stably expressed in a HEK293 cell line already stably expressing the pNiFty2-SEAP reporter plasmid; integration of the rep... | US Patent US10562861 (2020) BindingDB Entry DOI: 10.7270/Q22F7QTT | |||||||||||
More data for this Ligand-Target Pair |